Technical Analysis for MGNX - MacroGenics, Inc.

Grade Last Price % Change Price Change
grade F 13.08 -3.75% -0.51
MGNX closed down 3.75 percent on Friday, September 13, 2019, on 1.19 times normal volume.

Earnings due: Sep 27

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical MGNX trend table...

Date Alert Name Type % Chg
Down 3 Days in a Row Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
20 DMA Resistance Bearish -3.75%
MACD Bearish Signal Line Cross Bearish -3.75%
Fell Below 20 DMA Bearish -8.85%
MACD Bullish Signal Line Cross Bullish -8.85%
Crossed Above 20 DMA Bullish -9.29%
Stochastic Buy Signal Bullish -9.29%
Pocket Pivot Bullish Swing Setup -9.29%
Oversold Stochastic Weakness -9.29%

Older signals for MGNX ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
MacroGenics is a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer and autoimmune diseases. The company generates its pipeline of product candidates from its proprietary suite of next-generation antibody technology platforms, which it believes improve the performance of monoclonal antibodies and antibody-derived molecules. The company creates both differentiated molecules that are directed to novel cancer targets, as well as "bio-betters," which are drugs designed to improve upon marketed medicines. The combination of MacroGenics' technology platforms and antibody engineering expertise has allowed the company to generate promising product candidates and enter into several strategic collaborations with global pharmaceutical and biotechnology companies.
Medicine Biotechnology Biopharmaceutical Cancer Life Sciences Biology Immunology Treatment Of Cancer Antibodies Immune System Monoclonal Antibodies Autoimmune Diseases Antibody Technology Platforms Novel Cancer
Is MGNX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Indicators
Indicator Value
52 Week High 32.32
52 Week Low 9.87
Average Volume 373,164
200-Day Moving Average 16.2267
50-Day Moving Average 14.5538
20-Day Moving Average 14.251
10-Day Moving Average 13.763
Average True Range 0.7053
ADX 15.38
+DI 18.5861
-DI 30.7621
Chandelier Exit (Long, 3 ATRs ) 13.3641
Chandelier Exit (Short, 3 ATRs ) 14.9059
Upper Bollinger Band 15.6041
Lower Bollinger Band 12.8979
Percent B (%b) 0.07
BandWidth 18.989545
MACD Line -0.3065
MACD Signal Line -0.2549
MACD Histogram -0.0516
Fundamentals Value
Market Cap 481.32 Million
Num Shares 36.8 Million
EPS -4.19
Price-to-Earnings (P/E) Ratio -3.12
Price-to-Sales 56.93
Price-to-Book 2.96
PEG Ratio 0.01
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 14.59
Resistance 3 (R3) 14.66 14.23 14.34
Resistance 2 (R2) 14.23 13.84 14.19 14.25
Resistance 1 (R1) 13.65 13.61 13.44 13.58 14.17
Pivot Point 13.22 13.22 13.11 13.19 13.22
Support 1 (S1) 12.65 12.84 12.43 12.58 11.99
Support 2 (S2) 12.22 12.60 12.18 11.91
Support 3 (S3) 11.64 12.22 11.82
Support 4 (S4) 11.57